These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 4392273)

  • 1. Metabolism of aflatoxin in susceptible and resistant animal species.
    Patterson DS; Allcroft R
    Food Cosmet Toxicol; 1970 Feb; 8(1):43-53. PubMed ID: 4392273
    [No Abstract]   [Full Text] [Related]  

  • 2. Aflatoxin metabolism.
    Patterson DS; Roberts BA; Allcroft R
    Food Cosmet Toxicol; 1969 May; 7(3):277-8. PubMed ID: 5804864
    [No Abstract]   [Full Text] [Related]  

  • 3. Differences in the effect of phenobarbital treatment on the in vitro metabolism of aflatoxin and aniline by duck and rat livers.
    Patterson DS; Roberts BA
    Biochem Pharmacol; 1971 Dec; 20(12):3377-83. PubMed ID: 5132884
    [No Abstract]   [Full Text] [Related]  

  • 4. The role of aflatoxin metabolism in its toxic lesion.
    Campbell TC; Hayes JR
    Toxicol Appl Pharmacol; 1976 Feb; 35(2):199-222. PubMed ID: 4903
    [No Abstract]   [Full Text] [Related]  

  • 5. The formation of aflatoxins B2a and G2a and their degradation products during the in vitro detoxification of aflatoxin by livers of certain avian and mammalian species.
    Patterson DS; Roberts BA
    Food Cosmet Toxicol; 1970 Oct; 8(5):527-38. PubMed ID: 5492926
    [No Abstract]   [Full Text] [Related]  

  • 6. A comparative study of two procedures used in the determination of hepatic microsomal aniline hydroxylation.
    Chhabra RS; Gram TE; Fouts JR
    Toxicol Appl Pharmacol; 1972 May; 22(1):50-8. PubMed ID: 4402477
    [No Abstract]   [Full Text] [Related]  

  • 7. Ascorbic acid and drug metabolism.
    Zannoni VG; Flynn EJ; Lynch M
    Biochem Pharmacol; 1972 May; 21(10):1377-92. PubMed ID: 4402218
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of temperature on mixed function amine oxidase intrinsic fluorescence and oxidative activity.
    Kitchell BB; Rauckman EJ; Rosen GM
    Mol Pharmacol; 1978 Nov; 14(6):1092-8. PubMed ID: 32477
    [No Abstract]   [Full Text] [Related]  

  • 9. Oxidative metabolism of aflatoxin B 1 by mammalian liver slices and microsomes.
    Bassir O; Emafo PO
    Biochem Pharmacol; 1970 May; 19(5):1681-7. PubMed ID: 5513948
    [No Abstract]   [Full Text] [Related]  

  • 10. Steroid sex hormones as inhibitors of aflatoxin metabolism in liver homogenates.
    Patterson DS; Roberts BA
    Experientia; 1972 Aug; 28(8):929-30. PubMed ID: 4403936
    [No Abstract]   [Full Text] [Related]  

  • 11. Species differences and drug metabolism.
    Flynn EJ; Lynch M; Zannoni VG
    Biochem Pharmacol; 1972 Oct; 21(19):2577-90. PubMed ID: 4145289
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of protein deficiency on the hepatic microsomal mixed function oxidase. III-Influence on aflatoxin B1 metabolism and epoxide hydrase activity.
    Adekunle AA; Hayes JR; Campbell TC
    Biochem Exp Biol; 1978; 14(1):45-53. PubMed ID: 105748
    [No Abstract]   [Full Text] [Related]  

  • 13. Substrate and phenobarbital inducible aflatoxin-4-hydroxylation and aflatoxin metabolism by rat liver microsomes.
    Schabort JC; Steyn M
    Biochem Pharmacol; 1969 Sep; 18(9):2241-52. PubMed ID: 5345897
    [No Abstract]   [Full Text] [Related]  

  • 14. Aflatoxin metabolism in duck-liver homogenates: the relative importance of reversible cyclopentenone reduction and hemiacetal formation.
    Patterson DS; Roberts BA
    Food Cosmet Toxicol; 1972 Aug; 10(4):501-12. PubMed ID: 4404294
    [No Abstract]   [Full Text] [Related]  

  • 15. Sex and strain differences in basal and induced aniline hydroxylase and ethylmorphine N-demethylase activities from domestic and wild rats.
    Page JG; Vesell ES
    Pharmacology; 1969; 2(6):321-36. PubMed ID: 5362408
    [No Abstract]   [Full Text] [Related]  

  • 16. Kinetic changes in microsomal drug metabolism with age and diphenylhydantoin treatment.
    Eling TE; Harbison RD; Becker BA; Fouts JR
    Eur J Pharmacol; 1970 Jul; 11(1):101-8. PubMed ID: 4393448
    [No Abstract]   [Full Text] [Related]  

  • 17. On the spectral intermediate at 440 nm formed during mixed function substrate oxidation.
    Illing HP; Kunke S; Netter KJ
    Biochem Pharmacol; 1974 Sep; 23(18):2603-16. PubMed ID: 4153422
    [No Abstract]   [Full Text] [Related]  

  • 18. Hepatic microsomal mixed function oxygenase: enzyme multiplicity for the metabolism of carcinogens to DNA-binding metabolites.
    Gurtoo HL; Bejba N
    Biochem Biophys Res Commun; 1974 Nov; 61(2):735-42. PubMed ID: 4455244
    [No Abstract]   [Full Text] [Related]  

  • 19. The formation of 2,3-dihydroxy-2,3-dihydro-aflatoxin B1 by the metabolism of aflatoxin B1 by liver microsomes isolated from certain avian and mammalian species and the possible role of this metabolite in the acute toxicity of aflatoxin B1.
    Neal GE; Judah DJ; Stirpe F; Patterson DS
    Toxicol Appl Pharmacol; 1981 May; 58(3):431-7. PubMed ID: 6787737
    [No Abstract]   [Full Text] [Related]  

  • 20. Species differences in the metabolism of palmotoxins B0 and G0 in vitro.
    Bassir O; Emerole O
    Xenobiotica; 1975 Nov; 5(11):649-55. PubMed ID: 1189460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.